HypertensionNCT07267871
Oura Blood Pressure Profile Study
An observational study of Hypertension and High Blood Pressure, run by Ouraring Inc. at 1 site in United States.
Trial summary
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension. Read more about this study
- Who is it for?
- Ages 22 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hypertension, High Blood Pressure
- How many people
- 382,200 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Dec 2025to 12 Aug 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Participants will include users of the Oura Ring (Gen3 or newer) who are located in the United States and aged 22 years or older.
Who may be able to join
- Located in United States
- Aged 22 years or older at time of eligibility screener
- Oura Ring user (Oura Ring Gen3 or newer)
- User of the English version of the Oura App
- Smartphone (iOS or Android) user
- Able to provide consent electronically
Who cannot join
- User of implanted cardiac electronic device(s)
- Currently pregnant
- Within 12 weeks postpartum
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
- Conditions
- Hypertension, High Blood Pressure
- Medical subject headings
- Hypertension
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity of the Oura Blood Pressure Profile classification for identifying participant-reported hypertension
Measured: From enrollment until up to 18 months
Secondary outcomes (1)
Specificity of the Oura Blood Pressure Profile classification versus participant-reported hypertension
Measured: From enrollment until up to 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2025
- Study start17 Dec 2025
- Primary completion12 Aug 2026
- Study completion12 Aug 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 382,200 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ouraring Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07267871
- Sponsor's protocol ID
- HTN-2025
- Status last verified
- Aug 2026
- First submitted
- 14 Nov 2025
- Last updated
- 21 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension
- ClinicalTrials.gov ID
- NCT07267871
- Acronym / sponsor ID
- HTN-2025
- Conditions
- Hypertension, High Blood Pressure
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 382,200 participants (actual)
- Lead sponsor
- Ouraring Inc.Industry (pharma, biotech, devices)
- Study start
- 17 Dec 2025 (actual)
- Primary completion
- 12 Aug 2026 (actual)
- Study completion
- 12 Aug 2026 (actual)
- First posted
- 5 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Participants will include users of the Oura Ring (Gen3 or newer) who are located in the United States and aged 22 years or older.
Key inclusion criteria (6 listed)
- Located in United States
- Aged 22 years or older at time of eligibility screener
- Oura Ring user (Oura Ring Gen3 or newer)
- User of the English version of the Oura App
- Smartphone (iOS or Android) user
Key exclusion criteria (3 listed)
- User of implanted cardiac electronic device(s)
- Currently pregnant
- Within 12 weeks postpartum
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sensitivity of the Oura Blood Pressure Profile classification for identifying participant-reported hypertension
Time frame: From enrollment until up to 18 months
1 secondary outcome
Specificity of the Oura Blood Pressure Profile classification versus participant-reported hypertension
Time frame: From enrollment until up to 18 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Hypertension
Not yet recruiting
PAUL® Glaucoma Implant Safety and Effectiveness Study
Refractory Glaucoma
RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingObservational study
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
RecruitingPhase 1/2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Recruiting
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Fluid Accumulation, Blood Pressure Management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertension and High Blood Pressure, run by Ouraring Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensitivity of the Oura Blood Pressure Profile classification for identifying participant-reported hypertension (time frame: From enrollment until up to 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.